- Competitive alpha blocker
- Used in hypertensive emergencies like in pheochromocytoma; also in CRPS
- MOA: 3 times more specific for alpha 1 receptors than alpha 2. Doesn’t bind covalently to receptors; hence reversible. Also has beta agonistic and anti-serotoninergic activity
- Comes as pale yellow solution 10 mg/mL; dose is 1–5 mg titrated to effect
- CVS: Vasodilation and reduce BP, improve coronary artery perfusion, reduce pulmonary artery pressures. Alpha 2 blockade enhances noradrenaline release causing increase in HR and CO
- RESPIRATORY SYSTEM: Increase FEV1, increase secretions, prevents bronchospasm caused by histamine release
- Other Side Effects: Nasal congestion, Hypoglycemia (Causes insulin secretion)